BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35305687)

  • 21. The effect of perioperative immunonutrition on patients undergoing esophagectomy: a systematic review and updated meta-analysis.
    Zhou Y; Li TT; Yang ZL; Tan ZM; Yang CF; Wang Z
    Nutr Hosp; 2023 Aug; 40(4):839-847. PubMed ID: 37073747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications for neoadjuvant chemotherapy in older patients undergoing esophagectomy for esophageal cancer.
    Yamashita K; Momose K; Tanaka K; Makino T; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Eguchi H; Doki Y
    Surg Today; 2024 May; 54(5):442-451. PubMed ID: 37903923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy.
    Asaka S; Shimakawa T; Yamaguchi K; Murayama M; Shimazaki A; Katsube T; Naritaka Y
    Anticancer Res; 2016 Nov; 36(11):6165-6171. PubMed ID: 27793947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
    Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
    Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma.
    Ma S; Yan T; Liu D; Wang K; Wang J; Song J; Wang T; He W; Bai J; Jin L; Chen X
    Thorac Cancer; 2018 Feb; 9(2):310-315. PubMed ID: 29319236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer.
    Chen L; Sun L; Lang Y; Wu J; Yao L; Ning J; Zhang J; Xu S
    BMC Cancer; 2016 Jul; 16():449. PubMed ID: 27401305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of enteral immunonutrition on immune function in patients with multiple trauma.
    Li SL; Xu YH; Wang X; Liu XF; Zhao L
    World J Emerg Med; 2011; 2(3):206-9. PubMed ID: 25215011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol of a pilot randomized clinical trial to evaluate nutritional support and rehabilitation on prevention of skeletal muscle mass loss during neoadjuvant chemotherapy in patients with esophageal cancer.
    Miki Y; Nishi S; Tamura T; Imai T; Nambara M; Fukuoka T; Yoshii M; Toyokawa T; Lee S; Fujii H; Yoshida H; Ikebuchi M; Maeda K
    PLoS One; 2024; 19(4):e0302003. PubMed ID: 38635741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Enteral Immunonutrition on Immune, Inflammatory Markers and Nutritional Status in Gastric Cancer Patients Undergoing Gastrectomy: A Randomized Double-Blinded Controlled Trial.
    Li K; Xu Y; Hu Y; Liu Y; Chen X; Zhou Y
    J Invest Surg; 2020 Dec; 33(10):950-959. PubMed ID: 30885012
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy for esophageal cancer.
    Fujiwara Y; Lee S; Kishida S; Hashiba R; Gyobu K; Takemura M; Osugi H
    Surg Today; 2017 Nov; 47(11):1356-1360. PubMed ID: 28386749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an immuno-enhanced diet containing antioxidants in esophageal cancer surgery following neoadjuvant therapy.
    Aiko S; Kumano I; Yamanaka N; Tsujimoto H; Takahata R; Maehara T
    Dis Esophagus; 2012 Feb; 25(2):137-45. PubMed ID: 21762279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early enteral feeding on esophageal cancer patients after esophageal resection and reconstruction.
    Liao M; Xia Z; Huang P; Shi Q; Li H; He R; Bao M; Qiao K
    Ann Palliat Med; 2020 May; 9(3):816-823. PubMed ID: 32312065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of preoperative chemotherapy followed by esophagectomy versus upfront surgery for resectable esophageal squamous cell carcinoma.
    Kurogochi T; Honda M; Yamashita K; Hayami M; Okamura A; Imamura Y; Mine S; Watanabe M
    Surg Today; 2019 Feb; 49(2):150-157. PubMed ID: 30276466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietician-delivered intensive nutritional support is associated with a decrease in severe postoperative complications after surgery in patients with esophageal cancer.
    Ligthart-Melis GC; Weijs PJ; te Boveldt ND; Buskermolen S; Earthman CP; Verheul HM; de Lange-de Klerk ES; van Weyenberg SJ; van der Peet DL
    Dis Esophagus; 2013 Aug; 26(6):587-93. PubMed ID: 23237356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of postoperative complications after esophagectomy for esophageal cancer in patients receiving neoadjuvant therapy.
    Eguchi R; Ide H; Nakamura T; Hayashi K; Ohta M; Okamoto F; Itoh H; Takasaki K
    Jpn J Thorac Cardiovasc Surg; 1999 Nov; 47(11):552-8. PubMed ID: 10614095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Preoperative Nutritional Risk Screening and Enteral Nutrition Support in Accelerated Recovery after Resection for Esophageal Cancer.
    Shen Y; Zhou Y; He T; Zhuang X
    Nutr Cancer; 2021; 73(4):596-601. PubMed ID: 32400212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative oral supplementation support in patients with esophageal cancer.
    Kubota K; Kuroda J; Yoshida M; Okada A; Deguchi T; Kitajima M
    J Nutr Health Aging; 2014 Apr; 18(4):437-40. PubMed ID: 24676327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma.
    Nakaya S; Ogawa R; Hayakawa S; Fujihata S; Okubo T; Sagawa H; Tanaka T; Takahashi H; Matsuo Y; Takiguchi S
    World J Surg Oncol; 2021 Jul; 19(1):217. PubMed ID: 34281546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy.
    Tang Z; Zhu X; Li Y; Qu C; Li L; Li S; Qi L; Lu M; Cheng C; Tian H
    World J Surg Oncol; 2022 Jul; 20(1):239. PubMed ID: 35879767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.